Lamotrin-Mepha 5 mg
Lamotrin-Mepha 5 mg is a medicine authorised by Swissmedic under authorisation number 57137. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 July 2005 and the authorisation is valid without a time limit. ATC code N03AX09 places the medicine in the group Antiepileptics.
| Authorisation number | 57137 |
|---|---|
| Name | Lamotrin-Mepha 5 mg |
| Full name | Lamotrin-Mepha 5 mg, Kautabletten/dispergierbare Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX09 |
| First authorisation | 14 July 2005 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lamotrin-Mepha 5 mg, Kautabletten/dispergierbare Tabletten | B | 14 July 2005 |
| 2 | Lamotrin-Mepha 25 mg, Kautabletten/ dispergierbare Tabletten | B | 14 July 2005 |
| 3 | Lamotrin-Mepha 50 mg, Kautabletten/dispergierbare Tabletten | B | 14 July 2005 |
| 4 | Lamotrin-Mepha 100 mg, Kautabletten/dispergierbare Tabletten | B | 14 July 2005 |
| 5 | Lamotrin-Mepha 200 mg, Kautabletten/dispergierbare Tabletten | B | 14 July 2005 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 6 | 60 | Tablette(n) | N03AX09 | 01.07.1. | B |
| 10 | 60 | Tablette(n) | N03AX09 | 01.07.1. | B |
| 14 | 60 | Tablette(n) | N03AX09 | 01.07.1. | B |
| 18 | 60 | Tablette(n) | N03AX09 | 01.07.1. | B |
| 30 | 60 | Tablette(n) | N03AX09 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lamotrin-Mepha 5 mg authorised in Switzerland?
Yes. Lamotrin-Mepha 5 mg is authorised by Swissmedic under authorisation number 57137, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lamotrin-Mepha 5 mg have?
Lamotrin-Mepha 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lamotrin-Mepha 5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.